BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29777777)

  • 1. MiR-128-3p directly targets VEGFC/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca
    Zhou J; He Z; Guo L; Zeng J; Liang P; Ren L; Zhang M; Zhang P; Huang X
    Int J Biochem Cell Biol; 2018 Sep; 102():51-58. PubMed ID: 29777777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFC/VEGFR3 Signaling Regulates Mouse Spermatogonial Cell Proliferation via the Activation of AKT/MAPK and Cyclin D1 Pathway and Mediates the Apoptosis by affecting Caspase 3/9 and Bcl-2.
    Zhao L; Zhu Z; Yao C; Huang Y; Zhi E; Chen H; Tian R; Li P; Yuan Q; Xue Y; Wan Z; Yang C; Gong Y; He Z; Li Z
    Cell Cycle; 2018; 17(2):225-239. PubMed ID: 29169284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
    Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
    Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
    Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
    Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
    J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-455-3p regulates lymphangiogenesis in silicosis by regulating VEGF-C/VEGFR3.
    He H; Wang J; Zhang Y; Wang Y; Liu Y; Li X; Zhang Y; Yang J; Hao X; Wang H; Liu H
    Ecotoxicol Environ Saf; 2024 Jun; 278():116444. PubMed ID: 38728943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
    Chaudary N; Milosevic M; Hill RP
    Gynecol Oncol; 2011 Nov; 123(2):393-400. PubMed ID: 21839498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer.
    Tacconi C; Ungaro F; Correale C; Arena V; Massimino L; Detmar M; Spinelli A; Carvello M; Mazzone M; Oliveira AI; Rubbino F; Garlatti V; Spanò S; Lugli E; Colombo FS; Malesci A; Peyrin-Biroulet L; Vetrano S; Danese S; D'Alessio S
    Cancer Res; 2019 Aug; 79(16):4196-4210. PubMed ID: 31239267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
    Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
    Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
    Ichise T; Yoshida N; Ichise H
    PLoS One; 2012; 7(12):e51639. PubMed ID: 23284731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGFR3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways.
    Babaei Z; Panjehpour M; Ghorbanhosseini SS; Parsian H; Khademi M; Aghaei M
    J Cell Biochem; 2023 May; 124(5):674-686. PubMed ID: 36922713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/VEGFR3/AKT axis to ameliorate inflammatory bowel disease.
    Zhang L; Yuan J; Kofi Wiredu Ocansey D; Lu B; Wan A; Chen X; Zhang X; Qiu W; Mao F
    Int Immunopharmacol; 2022 Sep; 110():109066. PubMed ID: 35978512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc/Vegfr3 signaling in zebrafish.
    Kwon HB; Fukuhara S; Asakawa K; Ando K; Kashiwada T; Kawakami K; Hibi M; Kwon YG; Kim KW; Alitalo K; Mochizuki N
    Development; 2013 Oct; 140(19):4081-90. PubMed ID: 24046321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of vascular endothelial growth factor receptor 3 and vascular endothelial growth factor C in forebrain.
    Ward MC; Cunningham AM
    Neuroscience; 2015 Sep; 303():544-57. PubMed ID: 25943477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated lymphangiogenesis is critical in lymph node development and maturation.
    Lee YG; Koh GY
    Dev Dyn; 2016 Dec; 245(12):1189-1197. PubMed ID: 27623309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
    Dumond A; Montemagno C; Vial V; Grépin R; Pagès G
    Cells; 2021 May; 10(5):. PubMed ID: 34067671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.